Your Source for Venture Capital and Private Equity Financings

Select An Article

PerformYard Secures $95M
2024-01-09
ARLINGTON, VA, PerformYard announced today the completion of a $95 million equity investment from Updata Partners.
Read More
Lightmatter Lands Additional Financing
2024-01-09
BOSTON, MA, SIP Global Partners, a US-Japan VC firm investing in early-stage decarbonization technology, announced today its investment in Lightmatter.
Read More
Feel Therapeutics Announces New Funding
2024-01-09
SAN FRANCISCO, CA, Feel Therapeutics has secured new funding from Satori Neuro, Metavallon VC, and existing investors.
Read More
ClarisHealth Nabs Growth Investment
2024-01-09
BRENTWOOD, TN, ClarisHealth announced today that it secured a strategic growth investment from Pamlico Capital.
Read More
Bracket Labs Nabs $2M Pre-Seed Round
2024-01-09
Panama City, FL, Bracket Labs completed a $2 million pre-seed fundraise round to support the launch of 'Passage,' a volatility trading product available on the project's BracketX trading platform.
Read More
ExtraHop Raises $100M Growth Round
2024-01-09
SEATTLE, WA, ExtraHop, a leader in cloud-native network detection and response (NDR), today announced that it has secured $100 million in growth capital.
Read More
ThayerMahan Completes $20M Series C
2024-01-09
GROTON, CT, ThayerMahan, a world leader in autonomous maritime surveillance solutions, closed $20 million in follow-on Series C funding.
Read More
XRHealth Secures $6M
2024-01-09
BOSTON, MA, XRHealth, the leading healthcare platform in Spatial computing, announced today that the company secured $6 million in funding.
Read More
Rewst Receives $31M Series B Financing
2024-01-09
TAMPA, FL, Rewst, a purpose-built automation platform for Managed Service Providers (MSPs), today announced a $31 million Series B round.
Read More
Bolden Therapeutics Scoops Up New Funding
2024-01-09
NORWALK, CT, LifeSpan Vision Ventures, an investment firm that specializes in funding longevity biotech breakthroughs, today announced an investment in Bolden Therapeutics.
Read More
anecdotes Raises $25M Series B Round
2024-01-09
PALO ALTO, CA, anecdotes today announced that it has closed $25 million in a Series B round of funding.
Read More
MedaSystems Secures Additional Financing
2024-01-09
MENLO PARK, CA, MedaSystems, a pioneer in software to provide access to pre-approval medicine, announces additional funding from Debiopharm Innovation Fund.
Read More